Fmoc-Ala-Thr(Psi(Me,Me)pro)-OH

Fmoc-Ala-Thr(Psi(Me,Me)pro)-OH is an Fmoc-protected dipeptide-like amino acid derivative in which alanine is protected at the N-terminus by the fluorenylmethoxycarbonyl group, while the threonine side chain is modified with a Psi(Me,Me)pro motif that introduces a constrained, peptidomimetic character at the Thr position. The structure contains an Fmoc carbamate, a free carboxylic acid for coupling, and a stereodefined chiral threonine center, with the Psi substituent designed to mimic peptide backbone geometry and modulate conformational preferences. The Psi(Me,Me)pro functionality can participate in peptide coupling workflows while resisting undesired side reactions typical of unprotected hydroxyl-containing amino acid derivatives. The overall reactivity profile aligns with protected amino acid synthesis and solid-phase peptide assembly, enabling downstream formation of constrained peptide analogs for biochemical and SAR-oriented studies.

1. Peptide Synthesis

Fmoc-Ala-Thr(Psi(Me,Me)pro)-OH is suited for automated solid-phase peptide synthesis and peptide coupling chemistry where an Fmoc-protected N-terminus and a terminal carboxylic acid enable standard amide bond formation. The alanine residue provides a conventional α-amino acid coupling handle, while the stereodefined threonine bearing the Psi(Me,Me)pro side-chain constraint supports construction of backbone-modified sequences that can be assembled into longer peptides. The Fmoc group facilitates orthogonal deprotection strategies under base-promoted conditions, allowing sequential elongation without exposing the amine prematurely. The resulting constrained peptidomimetic peptides can be used to generate libraries of analogs for structure-activity relationship studies and to probe how conformational restriction influences molecular recognition.

2. Peptidomimetics SAR Studies

Fmoc-Ala-Thr(Psi(Me,Me)pro)-OH supports peptidomimetic design workflows aimed at interrogating how constrained threonine side-chain geometry impacts binding and selectivity in SAR studies. The Psi(Me,Me)pro motif introduces a sterically and conformationally biased element relative to native Thr(OH), which can be leveraged to tune hydrogen-bonding patterns and local backbone orientation within peptide scaffolds. The preserved stereochemistry at the threonine center enables stereospecific incorporation into analog series, supporting meaningful comparisons across epimeric or configurational variants. Downstream, the compound serves as a defined, stereochemically controlled building block for generating constrained peptide analogs suitable for iterative medicinal chemistry optimization and mechanistic binding investigations.

3. Chemical Biology Probes

Fmoc-Ala-Thr(Psi(Me,Me)pro)-OH can be applied in chemical biology research where peptide-based probes require stable incorporation of modified amino acid units to maintain structural integrity in complex environments. The Fmoc-protected amino functionality and the terminal carboxylic acid allow integration into probe peptides that subsequently undergo functional group transformations, such as side-chain derivatization or terminal labeling, depending on the target assay format. The Psi(Me,Me)pro constraint can reduce conformational heterogeneity, which may improve interpretability of structure-dependent cellular or biomolecular interactions measured with labeled peptide reagents. The compound therefore functions as a chemically defined intermediate for building constrained peptide probes that support downstream conjugation, imaging reagent synthesis, or affinity capture reagent preparation.

4. Bioconjugation Chemistry

Fmoc-Ala-Thr(Psi(Me,Me)pro)-OH is compatible with bioconjugation workflows that rely on peptide termini for controlled coupling to biomolecular targets or carrier scaffolds. The presence of a free carboxylic acid enables formation of activated derivatives for amide or ester linkage strategies after peptide assembly, while the Fmoc group supports clean stepwise synthesis prior to conjugation. The constrained threonine architecture can be carried into conjugated constructs to influence overall shape recognition and to help maintain the intended peptide conformation during conjugation and subsequent handling. The resulting conjugation-ready peptide intermediates can be used to generate biomolecule-modified reagents for affinity studies, pull-down assays, or mechanistic mapping of peptide-protein interactions.

5. Pharmaceutical Manufacturing Intermediates

Fmoc-Ala-Thr(Psi(Me,Me)pro)-OH can serve as a defined manufacturing intermediate for producing constrained peptide ingredients or peptide-based intermediates used in industrial fine chemical synthesis. The Fmoc protection strategy supports robust protection/deprotection cycles that are commonly integrated into scalable peptide manufacturing routes, while the terminal carboxylic acid provides a predictable coupling site for controlled assembly. The stereochemically fixed threonine residue and the Psi(Me,Me)pro side-chain constraint reduce ambiguity in downstream stereochemical outcomes during peptide elongation and purification. The compound can be employed to prepare sequence-specific peptide building blocks that feed into larger manufacturing campaigns for research-grade peptide materials, including analog series used in process development and analytical method qualification.

1. Oleic acid and glucose regulate glucagon-like peptide 1 receptor expression in a rat pancreatic ductal cell line

2. P-selectin and Complement’s Role in a Neonatal Model of Germinal Matrix Hemorrhage-Induced Secondary Injury

3. An Open-label, Single-center, Safety and Efficacy Study of Eyelash Polygrowth Factor Serum

4. Uncarboxylated osteocalcin decreases insulin-stimulated glucose uptake without affecting insulin signaling and regulators of mitochondrial biogenesis in myotubes

5. Implications of ligand-receptor binding kinetics on GLP-1R signalling